The applications to PhD Avdanced Course “Molecular Biomarkers and Technologies” are now open.
Biomarkers are now an integral part of the drug discovery and development process, acting as indicators of drug mechanism of action, efficacy, safety and disease progression, as well as assisting in disease diagnosis, patient selection and clinical trial design. Biomarkers also offer the potential to inform treatment
decisions and bring personalized medicine into clinical practice.
The training program is aimed at PhD students, but welcomes the participation of external academic and scientific community members.
Registrations up to 13th de september, here.
More information..
